Indian Journal of Endocrinology and Metabolism
Efficacy of Dapagliflozin vs. Saroglitazar on Hepatic Steatosis and Fibrosis in Patients of Type 2 Diabetes Mellitus and Metabolic-Associated Steatotic Liver Disease (MASLD)
Randomised trial in 101 peopleDapagliflozin